Cargando…

In vivo modelling of cutaneous T-cell lymphoma: The role of SOCS1

INTRODUCTION: Mycosis fungoides (MF), the most common type of Cutaneous T cell Lymphoma (CTCL), is characterized by an inflamed skin intermixed with proliferating malignant mature skin-homing CD4+ T cells. Detailed genomic analyses of MF skin biopsies revealed several candidate genes possibly involv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Yixin, Vermeer, Maarten H., de Gruijl, Frank R., Zoutman, Willem H., Sluijter, Marjolein, van Hall, Thorbald, Tensen, Cornelis P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730277/ https://www.ncbi.nlm.nih.gov/pubmed/36505769 http://dx.doi.org/10.3389/fonc.2022.1031052

Ejemplares similares

Socs1-knockout in skin-resident CD4(+) T cells in a protracted contact-allergic reaction results in an autonomous skin inflammation with features of early-stage mycosis fungoides
por: Luo, Yixin, et al.
Publicado: (2023)

Serum and cutaneous transcriptional expression levels of IL31 are minimal in cutaneous T cell lymphoma variants
por: van Santen, S., et al.
Publicado: (2021)

MicroRNA Profiling of Primary Cutaneous Large B-Cell Lymphomas
por: Koens, Lianne, et al.
Publicado: (2013)

Genomic analysis reveals recurrent deletion of JAK‐STAT signaling inhibitors HNRNPK and SOCS1 in mycosis fungoides
por: Bastidas Torres, Armando N., et al.
Publicado: (2018)

EPHA4 is overexpressed but not functionally active in Sézary syndrome
por: Hameetman, Liesbeth, et al.
Publicado: (2015)

Whole-genome profiling of primary cutaneous anaplastic large cell lymphoma
por: Torres, Armando N. Bastidas, et al.
Publicado: (2021)

Deregulation of JAK2 signaling underlies primary cutaneous CD8+ aggressive epidermotropic cytotoxic T-cell lymphoma
por: Torres, Armando N. Bastidas, et al.
Publicado: (2021)

Lgr6+ stem cells and their progeny in mouse epidermis under regimens of exogenous skin carcinogenesis, and their absence in ensuing skin tumors
por: van de Glind, Gerline C., et al.
Publicado: (2016)

Pathogenesis of Skin Carcinomas and a Stem Cell as Focal Origin
por: de Gruijl, Frank R., et al.
Publicado: (2018)

Genetic rearrangements result in altered gene expression and novel fusion transcripts in Sézary syndrome
por: Przybylski, Grzegorz K., et al.
Publicado: (2017)

Epidemiology of cutaneous lymphoma
por: Vermeer, M.
Publicado: (2021)

Update on Biology of Cutaneous T-Cell Lymphoma
por: Phyo, Zaw H., et al.
Publicado: (2020)

Cucurbitacin E and I target the JAK/STAT pathway and induce apoptosis in Sézary cells
por: Brouwer, Isabella J., et al.
Publicado: (2020)

The Role of an Integrated Multidisciplinary Clinic in the Management of Patients with Cutaneous Lymphoma
por: Tyler, Kelly H., et al.
Publicado: (2015)

Immunomodulation in Cutaneous T Cell Lymphoma
por: Ferranti, Martina, et al.
Publicado: (2019)

Editorial: Cutaneous T-Cell Lymphomas
por: Chung, Catherine G., et al.
Publicado: (2021)

Molecular profiling of cutaneous squamous cell carcinomas and actinic keratoses from organ transplant recipients
por: Hameetman, Liesbeth, et al.
Publicado: (2013)

Editorial: Cutaneous B-Cell Lymphomas
por: Alaibac, Mauro, et al.
Publicado: (2020)

Clinical and pathogenic aspects of the severe cutaneous adverse reaction epidermal necrolysis (EN)
por: Kuijper, E.C., et al.
Publicado: (2020)

Cell-of-origin classification using the Hans and Lymph2Cx algorithms in primary cutaneous large B-cell lymphomas
por: Schrader, Anne M. R., et al.
Publicado: (2022)

CAR-Based Approaches to Cutaneous T-Cell Lymphoma
por: Scarfò, Irene, et al.
Publicado: (2019)

Skin Directed Therapy in Cutaneous T-Cell Lymphoma
por: Tarabadkar, Erica S., et al.
Publicado: (2019)

Primary Cutaneous B-Cell Lymphomas: An Update
por: Vitiello, Paola, et al.
Publicado: (2020)

An Update on Molecular Biology of Cutaneous T Cell Lymphoma
por: Walia, Ritika, et al.
Publicado: (2020)

Epigenetics in the Pathogenesis and Treatment of Cutaneous T-Cell Lymphoma
por: Zhang, Ping, et al.
Publicado: (2021)

Advances in the understanding and treatment of Cutaneous T-cell Lymphoma
por: Bakr, Farrah S., et al.
Publicado: (2022)

Editorial: Advances in the understanding and treatment of cutaneous lymphoma
por: Bernardelli, Andrea, et al.
Publicado: (2023)

Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator
por: Ottevanger, Rosanne, et al.
Publicado: (2022)

Flow cytometry for the assessment of blood tumour burden in cutaneous T‐cell lymphoma: towards a standardized approach
por: Vermeer, Maarten H., et al.
Publicado: (2022)

Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection
por: GOSMANN, Janika, et al.
Publicado: (2023)

New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma
por: Fujii, Kazuyasu
Publicado: (2018)

Biological Approaches to Aggressive Cutaneous B-Cell Lymphomas
por: Tadiotto Cicogna, Giulia, et al.
Publicado: (2019)

Harnessing the immune system in the treatment of cutaneous T cell lymphomas
por: Fay, Christopher J., et al.
Publicado: (2023)

T cells specific for a TAP-independent self-peptide remain naïve in tumor-bearing mice and are fully exploitable for therapy
por: Doorduijn, Elien M., et al.
Publicado: (2017)

Innovative Therapeutic Approaches in Primary Cutaneous B Cell Lymphoma
por: Lang, Claudia C. V., et al.
Publicado: (2020)

Primary Cutaneous B-Cell Lymphomas in Patients With Impaired Immunity
por: Russo, Irene, et al.
Publicado: (2020)

Quality of Life in Cutaneous T-cell Lymphoma Patients Receiving Mogamulizumab: Important Factors to Consider
por: Ottevanger, Rosanne, et al.
Publicado: (2022)

Reply to Correspondence to “Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator”
por: Ottevanger, Rosanne, et al.
Publicado: (2022)

Metabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFNγ receptor signaling
por: Marijt, Koen A., et al.
Publicado: (2019)

A rare case of cutaneous Epstein-Barr virus–negative intravascular cytotoxic T-cell lymphoma
por: Melchers, Rutger C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_79hmvuojpfkgccp73huvahrte5